Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spragg, R.
Right arrow Articles by Strayer, D
Right arrow Search for Related Content
PubMed
Right arrow Articles by Spragg, R.
Right arrow Articles by Strayer, D

Chest, Vol 105, 195-202, Copyright © 1994 by American College of Chest Physicians

ARTICLES

Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome

RG Spragg, N Gilliard, P Richman, RM Smith, RD Hite, D Pappert, B Robertson, T Curstedt and D Strayer
Department of Medicine, University of California, San Diego.

In an attempt to restore functional surfactant to the lungs of patients with the adult respiratory distress syndrome (ARDS), we have treated six patients within the first 2 days of the onset of ARDS with a single dose of hydrophobic components of porcine surfactant. Surfactant (4 g in 50 ml) delivered via a bronchoscope in aliquots to each of the lobar bronchi was well tolerated and caused a modest transient improvement in gas exchange. No significant changes in chest radiograph or lung compliance were detected. Analysis of bronchoalveolar lavage (BAL) fluid showed no change in albumin, alpha-1-proteinase inhibitor specific activity, or cell count. Bronchoalveolar lavage phospholipid concentrations were elevated 3 h after surfactant administration relative to preadministration levels and fell by 24 h. In addition, in two patients we found reduced inhibition of surfactant function in BAL after surfactant replacement. These observations suggest a role for surfactant replacement in the treatment of patients with ARDS and support the need for continuing investigation.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
W. Huang, L. A. McCaig, R. A. W. Veldhuizen, L-J. Yao, and J. F. Lewis
Mechanisms responsible for surfactant changes in sepsis-induced lung injury
Eur. Respir. J., December 1, 2005; 26(6): 1074 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
B. S. Burleson and E. D. Maki
Acute Respiratory Distress Syndrome
Journal of Pharmacy Practice, April 1, 2005; 18(2): 118 - 131.
[Abstract] [PDF]

Home page
 NEJMHome page
R. G. Spragg, J. F. Lewis, H.-D. Walmrath, J. Johannigman, G. Bellingan, P.-F. Laterre, M. C. Witte, G. A. Richards, G. Rippin, F. Rathgeb, et al.
Effect of Recombinant Surfactant Protein C-Based Surfactant on the Acute Respiratory Distress Syndrome
N. Engl. J. Med., August 26, 2004; 351(9): 884 - 892.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y.-Z. Wu, S. Medjane, S. Chabot, F. S. Kubrusly, I. Raw, M. Chignard, and L. Touqui
Surfactant Protein-A and Phosphatidylglycerol Suppress Type IIA Phospholipase A2 Synthesis via Nuclear Factor-{kappa}B
Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 692 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. G. Spragg, J. F. Lewis, W. Wurst, D. Hafner, R. P. Baughman, M. D. Wewers, and J. J. Marsh
Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1562 - 1566.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Gunther, R. Schmidt, J. Harodt, T. Schmehl, D. Walmrath, C. Ruppert, F. Grimminger, and W. Seeger
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties
Eur. Respir. J., May 1, 2002; 19(5): 797 - 804.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Walmrath, F. Grimminger, D. Pappert, C. Knothe, U. Obertacke, A. Benzing, A. Gunther, T. Schmehl, H. Leuchte, and W. Seeger
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics
Eur. Respir. J., May 1, 2002; 19(5): 805 - 810.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. G. Brower, L. B. Ware, Y. Berthiaume, and M. A. Matthay
Treatment of ARDS
Chest, October 1, 2001; 120(4): 1347 - 1367.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
E. P. Ingenito, R. Mora, M. Cullivan, Y. Marzan, K. Haley, L. Mark, and L. A. Sonna
Decreased Surfactant Protein-B Expression and Surfactant Dysfunction in a Murine Model of Acute Lung Injury
Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 35 - 44.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. G. Spragg, R. M. Smith, K. Harris, J. Lewis, D. Hafner, and P. Germann
Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury
J Appl Physiol, February 1, 2000; 88(2): 674 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. T. SCHERMULY, A. GÜNTHER, N. WEISSMANN, H. A. GHOFRANI, W. SEEGER, F. GRIMMINGER, and D. WALMRATH
Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (VA/Q) Mismatch in a Model of Acute Lung Injury
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 152 - 159.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. E. WISWELL, R. M. SMITH, L. B. KATZ, L. MASTROIANNI, D. Y. WONG, D. WILLMS, S. HEARD, M. WILSON, R. D. HITE, A. ANZUETO, et al.
Bronchopulmonary Segmental Lavage with Surfaxin (KL4-Surfactant) for Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1188 - 1195.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
T. Kobayashi, K. Ohta, K. Tashiro, K. Nishizuka, W.-M. Chen, S. Ohmura, and K. Yamamoto
Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract
J Appl Physiol, June 1, 1999; 86(6): 1778 - 1784.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. LEWIS, L. MCCAIG, D. HÄFNER, R. SPRAGG, R. VELDHUIZEN, and C. KERR
Dosing and Delivery of a Recombinant Surfactant in Lung-injured Adult Sheep
Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 741 - 747.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
C. L. Kerr, Y. Ito, S. E. E. Manwell, R. A. W. Veldhuizen, L.-J. Yao, L. A. McCaig, and J. F. Lewis
Effects of surfactant distribution and ventilation strategies on efficacy of exogenous surfactant
J Appl Physiol, August 1, 1998; 85(2): 676 - 684.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. Halpern, O. E. Jensen, and J. B. Grotberg
A theoretical study of surfactant and liquid delivery into the lung
J Appl Physiol, July 1, 1998; 85(1): 333 - 352.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
V. BALARAMAN, J. MEISTER, T. L. KU, S. L. SOOD, E. TAM, J. KILLEEN, C. F. T. UYEHARA, E. EGAN, and D. EASA
Lavage Administration of Dilute Surfactants after Acute Lung Injury in Neonatal Piglets
Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 12 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. ARTIGAS, G. R. BERNARD, J. CARLET, D. DREYFUSS, L. GATTINONI, L. HUDSON, M. LAMY, J. J. MARINI, M. A. MATTHAY, M. R. PINSKY, et al.
The American-European Consensus Conference on ARDS, Part 2 . Ventilatory, Pharmacologic, Supportive Therapy, Study Design Strategies, and Issues Related to Recovery and Remodeling
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1332 - 1347.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
T. F. Fok, M. Al-Essa, M. Dolovich, F. Rasid, and H. Kirpalani
Nebulisation of surfactants in an animal model of neonatal respiratory distress
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1998; 78(1): 3F - 9.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. M. Manuel, Y. Guo, and S. Matalon
Exosurf enhances adenovirus-mediated gene transfer to alveolar type II cells
Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L741 - L748.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. Anzueto, R. P. Baughman, K. K. Guntupalli, J. G. Weg, H. P. Wiedemann, A. A. Raventos, F. Lemaire, W. Long, D. S. Zaccardelli, E. N. Pattishall, et al.
Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome
N. Engl. J. Med., May 30, 1996; 334(22): 1417 - 1422.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.